Context Therapeutics e The Menarini Group anunciam colaboração de estudos clínicos e acordo de fornecimento para avaliar a combinação ONA-XR e Elacestranto ...Middle East

Dados pré-clínicos suportam o potencial de degradadores de receptor de ONA-XR mais estrogênio em modelos de doenças resistentes à endócrina Context inicia estudo clínico de Fase 1b/2 no quarto trimestre de 2022 FILADÉLFIA e FLORENÇA, Itália, 3 de agosto de 2022 /PRNewswire/ -- A Context...

Hence then, the article about context therapeutics e the menarini group anunciam colaboracao de estudos clinicos e acordo de fornecimento para avaliar a combinacao ona xr e elacestranto was published today ( Wednesday 03/08/2022 - 11:52 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Context Therapeutics e The Menarini Group anunciam colaboração de estudos clínicos e acordo de fornecimento para avaliar a combinação ONA-XR e Elacestranto )

Also on site :

• Aura AI Assistant for Unreal Engine Launches: VR Studio Ships Game in Half the Time with New Agent Capabilities
• Man accused of placing pipe bombs near GOP and Democratic headquarters in Washington to remain in jail pending trial
• FDA Clears BrainSpace Intellidrop, an automated neuro device that addresses ICU nursing shortages and builds training data for Physical AI